🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #406

Cancer - Press Review (June 16, 2012) – Revue de presse (16 juin 2012)

#406
From: SMW
Date: Sat, 16 Jun 2012 19:05
189 lines
9460 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (June 16, 2012) – Revue de presse (16 juin 2012)

WHO agency: Diesel fumes cause cancer
Diesel fumes cause cancer, the World Health Organization's cancer
agency declared Tuesday, a ruling it said could make exhaust as
important a public health threat as secondhand smoke.
In USA Today
http://www.usatoday.com/news/health/story/2012-06-13/cancer-diesel-exhaust-who/55579410/1

US cancer survivors to rise by a third by 2022-report
The number of Americans living with cancer will increase by nearly a
third to almost 18 million by 2022, according to a report released on
Th ursday by the American Cancer Society and the National Cancer
Institute.
In Reuters
http://www.reuters.com/article/2012/06/14/usa-cancer-projections-idUSL1E8HB7MX20120614

Cancer-fighting virus 'piggybacks' on blood cells
A promising type of cancer treatment called viral therapy avoids
detection by the body's immune system and reaches tumours by
'piggybacking' on blood cells.
In Cancer Research UK
http://info.cancerresearchuk.org/news/archive/cancernews/2012-06-13-Cancer-fighting-virus-piggybacks-on-blood-cells

In one type of cancer, heavier men may live longer
Extra pounds may not be good for your health in general, but heavy men
appear more likely to survive a particular form of immune system
cancer, a new study finds.
By Amy Norton. In Reuters
http://www.reuters.com/article/2012/06/12/us-cancer-heavier-men-idUSBRE85B19620120612

Young Cancer Survivors Often Face Long-Term Health Problems
Many teens and young adults who survive cancer face other challenges
later in life, such as unhealthy behaviors, chronic medical conditions
and poor quality of life, according to a new report.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/06/11/young-cancer-survivors-often-face-long-term-health-problems

Does More Dental Plaque Mean Higher Chances of Dying From Cancer?
The gnarly plaque lurking on your gums and teeth may increase your
chances of dying from cancer, new research suggests.
By Denise Mann. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/06/12/does-more-dental-plaque-mean-higher-chances-of-dying-from-cancer

Revealing Colon Cancer's Escape Route‎Taking periodic breaks from a
Researchers have figured out why a popular therapy for treating colon
cancer often eventually stops working: The tumors naturally carry
genetic changes that allow some of their cells to evade the drug and
keep growing. The good news is that physicians may be able to detect
these changes in patients' blood and then halt the cancer with a
different drug before it can grow again to a dangerous size.
By Jocelyn Kaiser. In Science AAAS
http://news.sciencemag.org/sciencenow/2012/06/revealing-colon-cancers-escape.html

Identifying the origins of cervical cancer
Researchers from Brigham and Women's Hospital uncover a population of
cells that are targeted by the cancer-causing human papillomaviruses
In EurekAlert
http://www.eurekalert.org/pub_releases/2012-06/bawh-ito060812.php

FDA Approves Pertuzumab (Perjeta) for HER2-Positive Breast Cancer
Patients with HER2-positive breast cancer now have a new treatment
option. Last week the US Food and Drug Administration (FDA) approved
pertuzumab (Perjeta), a HER2-targeted antibody. The drug is approved
in combination with trastuzumab (Herceptin) and docetaxel chemotherapy
for women whose breast cancer overexpress the HER2 receptor and who
have not received prior systemic treatment such as chemotherapy or
trastuzumab monotherapy.
By Anna Azvolinsky. In Cancer Network
http://www.cancernetwork.com/breast-cancer/content/article/10165/2082951

New clinical trial design promises to accelerate cancer drug approvals
Patients with early-stage breast cancer usually have to wait years to
receive new cancer drugs but new guidance from the Food and Drug
Administration (FDA)  promises to reduce substantially the time and
cost of getting new treatments to patients.  The approach is based on
a trial design being tested in the I-SPY 2 TRIAL, an innovative Phase
II breast cancer trial
By Erika Matich. In Medical Xpress
http://medicalxpress.com/news/2012-06-clinical-trial-cancer-drug.html


Les risques de cancer restent mal évalués‎‎
Le cancer est considéré comme "la maladie la plus grave" par 71 % des
Français, devant le sida et les maladies cardio-vasculaires. C'est ce
qui ressort du baromètre 2010 de l'Institut national de prévention et
d'éducation pour la santé (Inpes) et de l'Institut national du cancer
(INCa), publié jeudi 14 juin. L'enquête a été réalisée par téléphone
auprès de 3 728 personnes, d'avril à août 2010. La précédente datait
de 2005.
Par Pascale Santi. Dans Le Monde
http://www.lemonde.fr/vous/article/2012/06/14/les-risques-de-cancer-restent-mal-evalues_1718619_3238.html

Diesel : les gaz d'échappement considérés comme cancérigènes
En cause : leur implication dans des cas de cancers du poumon et de la
vessie. Les gaz d'échappement des moteurs diesel sont « cancérigènes
pour l'Homme »
Dans Futura- Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/diesel-les-gaz-dechappement-consideres-comme-cancerigenes_39381/

Cancer du sein: les Etats-Unis approuvent un traitement du laboratoire
Roche
L'Agence américaine des médicaments (FDA) a approuvé la molécule
Perjeta, utilisée en combinaison avec un autre traitement contre le
cancer, le Herceptin, et une chimiothérapie avec le docetaxel, pour
traiter les patientes souffrant d'un cancer du sein HER2 positif
n'ayant pas encore reçu de traitement.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5gK5EEiBYe--eUQK6YQkfpTofacIg?docId=CNG.d5af4012c8e2d8c95005308729de1d22.511

Cancer de la vessie : pourquoi le BCG est l’une des meilleures armes ?
Le BCG est utilisé depuis 35 ans pour éviter les récidives dans les
cancers de la vessie car il a prouvé son efficacité. Mais comment
l’optimiser ? La réponse vient d’être apportée : le traitement est
d’autant plus efficace que le patient est au préalable immunisé contre
la tuberculose…
Par Janlou Chaput. Dans Futura-Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-de-la-vessie-pourquoi-le-bcg-est-lune-des-meilleures-armes_39279/

Découverte d'une zone de cellules responsables des cancers de l'utérus
"La plupart, sinon tous" les cancers utérins, provoqués en majorité
par des papillomavirus humains, se développent dans des cellules
spécifiques situées dans une seule région du col de l'utérus, selon
des travaux publiés lundi aux Etats-Unis.
Dans Le Nouvel Observateur
http://tempsreel.nouvelobs.com/topnews/20120611.AFP9056/decouverte-d-une-zone-de-cellules-responsables-des-cancers-de-l-uterus.html

Les scanners chez l'enfant augmentent le risque de cancer‎
L'irradiation délivrée dans l'enfance par 2 ou 3 scanners cérébraux
triple le risque de cancer du cerveau. Et il faut 5 Ă  10 scanners du
cerveau pour tripler  le risque de leucémie.
Dans Le Nouvel Observateur
http://pourquoi-docteur.nouvelobs.com/Les-scanners-chez-l-enfant-augmentent-le-risque-de-cancer-854.html






Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (06/2012)
Technical Details
Message-ID: <6e3c5e86-dd4a-421e-b708-cca8a28ae78f@l5g2000vbo.googlegroups.com>
Path: arc1-ca.pugleaf.net!l9ni58307pbj.0!nntp.google.com!news1.google.com!postnews.google.com!l5g2000vbo.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,5f60a1e2c0e834ec,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.234.38 with SMTP id ub6mr10452622pbc.2.1339873545375;
        Sat, 16 Jun 2012 12:05:45 -0700 (PDT)
Path: arc1-ca.pugleaf.net!l9ni58307pbj.0!nntp.google.com!news1.google.com!postnews.google.com!l5g2000vbo.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (June 16, 2012) – Revue de presse (16 juin 2012)
Date: Sat, 16 Jun 2012 12:05:44 -0700 (PDT)
Organization: http://groups.google.com
Lines: 189
Message-ID: <6e3c5e86-dd4a-421e-b708-cca8a28ae78f@l5g2000vbo.googlegroups.com>
NNTP-Posting-Host: 81.247.94.191
Mime-Version: 1.0
X-Trace: posting.google.com 1339873545 19062 127.0.0.1 (16 Jun 2012 19:05:45 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 16 Jun 2012 19:05:45 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: l5g2000vbo.googlegroups.com; posting-host=81.247.94.191; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.10.289 Version/12.00,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable